))
Rheumatology/Psoriatic Arthritis Edition: Top Headlines for Week of August 19, 2024
Manage episode 435580252 series 3560281
Innhold levert av Healio. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Healio eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
In this edition, drug discounts through Medicare price negotiations, opioid use has fallen 15% annually since 2014 and more. Read the full coverage here:
Enbrel, Stelara to be discounted nearly 70% through Medicare price negotiations
Opioid use has fallen 15% annually since 2014 in autoimmune rheumatic disease
Inhibitor class PsO treatments exhibit similar efficacy in mitigating PsA risk
S100 protein levels predict abatacept response in juvenile idiopathic arthritis
Izokibep shows early promise in hidradenitis suppurativa
References:
Brunner HI, et al. Arthritis Res Ther. 2024;doi:10.1186/s13075-024-03347-0.
Falasinnu T, et al. Lancet Rheumatol. 2024;doi:10.1016/S2665-9913(24)00120-6.
Tsai SHL, et al. J Am Acad Dermatol. 2024;doi:10.1016/j.jaad.2024.07.1473.
115 episoder
Del
